Isabelle Meynial-Salles

This inventor holds 5 USPTO granted patents, plus 4 CIPO patents and 5 EPO patents. Top assignees: Metabolic Explorer, Centre National De La Recherche Scientifique, Institut National Des Sciences Appliquees. Active years: 2010-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Isabelle Meynial-Salles. Retrieved from https://idiyas.com/inventor/isabelle-meynial-salles

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5

% Patents Active = 60.0

CIPO Patents = 4

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 2

Forward Citations = 14(Granted Patents)

Company Filing History:

Centre National De La Recherche Scientifique

patents

2 out of 17

Institut National Des Sciences Appliquees

patents

4. 2 out of 285

National Institute for Agricultural Research

patents

where one patent can have more than one assignee

Years Active: 2010-2020

Loading Chart...

5 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10760100 - Polypeptide having ferredoxin-NADP+ reductase activity, polynucleotide encoding the same and uses thereof (2020-09-01),

2. 10669530 - strains unable to produce hydrogen and useful for the continuous production of chemicals and fuels (2020-06-02),

3. 8980604 - Mutant glycerol dehydrogenase (GlyDH) for the production of a biochemical by fermentation (2015-03-17),

4. 8252579 - Evolved micro-organisms for the production of 1,2-propanediol (2012-08-28),

5. 7745195 - Method for the preparation of an evolved microorganism for the creation or the modification of metabolic pathways (2010-06-29),

Title: Innovations of Isabelle Meynial-Salles

Introduction

Isabelle Meynial-Salles is a prominent inventor based in Fourquevaux, France. She has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides and microorganisms for the production of valuable chemicals.

Latest Patents

Isabelle holds five patents, with her latest inventions focusing on a polypeptide that exhibits ferredoxin-NADP+ reductase activity. This invention involves a polynucleotide that encodes the polypeptide and explores its applications in modulating enzymatic activity in microorganisms. Additionally, she has developed a new strain of microorganisms that are modified to be unable to produce hydrogen, which can continuously produce bulk chemicals such as lactate, ethanol, and butanol at high yields.

Career Highlights

Throughout her career, Isabelle has worked with notable organizations, including Metabolic Explorer and the National Institute of Applied Sciences (Institut National Des Sciences Appliquées). Her work has been instrumental in advancing the field of microbial biotechnology and chemical production.

Collaborations

Isabelle has collaborated with esteemed colleagues such as Philippe Soucaille and Benjamin Gonzalez, contributing to various research projects and innovations in her field.

Conclusion

Isabelle Meynial-Salles is a trailblazer in biotechnology, with her innovative patents and collaborations paving the way for advancements in sustainable chemical production. Her work continues to impact the industry positively.

Profile summary based on public USPTO records.